# Renasant Corp: financial statements, quarterly

RNST · NYSE · CIK 715072 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rnst.md) · [Financials](/companies/rnst/financials.md) · [Filings](/companies/rnst/filings.md) · [Insiders](/companies/rnst/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rnst/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [78.3](/filings/0000715072-23-000250.md) | [84.5 d](/filings/0000715072-24-000042.md) | [89.9](/filings/0000715072-24-000130.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [10.8](/filings/0000715072-24-000186.md) | [3.8 d](/filings/0000715072-26-000017.md) | [9.9](/filings/0000715072-25-000180.md) | [9.7](/filings/0000715072-25-000211.md) | [24.9](/filings/0000715072-25-000234.md) | [5.0 d](/filings/0000715072-26-000017.md) | [10.4](/filings/0000715072-26-000046.md) | [1.6](/filings/0000715072-26-000072.md) | [15.5](/filings/0000715072-25-000234.md) | [17.9 d](/filings/0000715072-26-000017.md) | [22.2](/filings/0000715072-26-000046.md) | [21.6](/filings/0000715072-26-000072.md) |
| Net income | $m | [41.8](/filings/0000715072-24-000186.md) | [28.1 d](/filings/0000715072-26-000017.md) | [39.4](/filings/0000715072-25-000234.md) | [38.8](/filings/0000715072-25-000234.md) | [72.5](/filings/0000715072-25-000234.md) | [44.7 d](/filings/0000715072-26-000017.md) | [41.5](/filings/0000715072-26-000072.md) | [1.0](/filings/0000715072-26-000072.md) | [59.8](/filings/0000715072-25-000234.md) | [78.9 d](/filings/0000715072-26-000017.md) | [88.2](/filings/0000715072-26-000072.md) | [87.1](/filings/0000715072-26-000072.md) |
| Diluted EPS | $ per share | [0.74](/filings/0000715072-24-000186.md) | not reported | [0.70](/filings/0000715072-25-000180.md) | [0.69](/filings/0000715072-25-000211.md) | [1.18](/filings/0000715072-25-000234.md) | not reported | [0.65](/filings/0000715072-26-000046.md) | [0.01](/filings/0000715072-26-000072.md) | [0.63](/filings/0000715072-25-000234.md) | not reported | [0.94](/filings/0000715072-26-000046.md) | [0.94](/filings/0000715072-26-000072.md) |
| Basic EPS | $ per share | [0.75](/filings/0000715072-24-000186.md) | not reported | [0.70](/filings/0000715072-25-000180.md) | [0.69](/filings/0000715072-25-000211.md) | [1.18](/filings/0000715072-25-000234.md) | not reported | [0.65](/filings/0000715072-26-000046.md) | [0.01](/filings/0000715072-26-000072.md) | [0.63](/filings/0000715072-25-000234.md) | not reported | [0.94](/filings/0000715072-26-000046.md) | [0.95](/filings/0000715072-26-000072.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.7](/filings/0000715072-23-000250.md) | [0.8](/filings/0000715072-25-000054.md) | [0.8](/filings/0000715072-24-000130.md) | [0.9](/filings/0000715072-24-000155.md) | [1.3](/filings/0000715072-24-000186.md) | [1.1](/filings/0000715072-26-000017.md) | [1.1](/filings/0000715072-25-000180.md) | [1.4](/filings/0000715072-25-000211.md) | [1.1](/filings/0000715072-25-000234.md) | [1.1](/filings/0000715072-26-000072.md) | [1.2](/filings/0000715072-26-000046.md) | [0.9](/filings/0000715072-26-000072.md) |
| Total assets | $bn | [17.2](/filings/0000715072-24-000186.md) | [17.4](/filings/0000715072-26-000017.md) | [17.3](/filings/0000715072-25-000180.md) | [17.5](/filings/0000715072-25-000211.md) | [18.0](/filings/0000715072-25-000234.md) | [18.0](/filings/0000715072-26-000017.md) | [18.3](/filings/0000715072-26-000046.md) | [26.6](/filings/0000715072-26-000072.md) | [26.7](/filings/0000715072-25-000234.md) | [26.8](/filings/0000715072-26-000072.md) | [27.1](/filings/0000715072-26-000046.md) | [27.0](/filings/0000715072-26-000072.md) |
| Total liabilities | $bn | [14.9](/filings/0000715072-23-000250.md) | [15.1](/filings/0000715072-25-000054.md) | [15.0](/filings/0000715072-24-000130.md) | [15.2](/filings/0000715072-24-000155.md) | [15.3](/filings/0000715072-24-000186.md) | [15.4](/filings/0000715072-26-000017.md) | [15.5](/filings/0000715072-25-000180.md) | [22.8](/filings/0000715072-25-000211.md) | [22.9](/filings/0000715072-25-000234.md) | [22.9](/filings/0000715072-26-000072.md) | [23.2](/filings/0000715072-26-000046.md) | [23.1](/filings/0000715072-26-000072.md) |
| Long-term debt | $bn | [0.4](/filings/0000715072-23-000250.md) | [0.4](/filings/0000715072-25-000054.md) | [0.4](/filings/0000715072-24-000130.md) | [0.4](/filings/0000715072-24-000155.md) | [0.4](/filings/0000715072-24-000186.md) | [0.4](/filings/0000715072-26-000017.md) | [0.4](/filings/0000715072-25-000180.md) | [0.6](/filings/0000715072-25-000211.md) | [0.6](/filings/0000715072-25-000234.md) | [0.5](/filings/0000715072-26-000072.md) | [0.5](/filings/0000715072-26-000046.md) | [0.8](/filings/0000715072-26-000072.md) |
| Short-term borrowings | $bn | [0.1](/filings/0000715072-23-000250.md) | [0.3](/filings/0000715072-25-000054.md) | [0.1](/filings/0000715072-24-000130.md) | [0.2](/filings/0000715072-24-000155.md) | [0.1](/filings/0000715072-24-000186.md) | [0.1](/filings/0000715072-26-000017.md) | [0.1](/filings/0000715072-25-000180.md) | [0.4](/filings/0000715072-25-000211.md) | [0.6](/filings/0000715072-25-000234.md) | [0.6](/filings/0000715072-26-000072.md) | [0.3](/filings/0000715072-26-000046.md) | [0.3](/filings/0000715072-26-000072.md) |
| Shareholders' equity | $bn | [2.2](/filings/0000715072-24-000186.md) | [2.3](/filings/0000715072-26-000017.md) | [2.3](/filings/0000715072-25-000234.md) | [2.4](/filings/0000715072-25-000234.md) | [2.7](/filings/0000715072-25-000234.md) | [2.7](/filings/0000715072-26-000072.md) | [2.7](/filings/0000715072-26-000072.md) | [3.8](/filings/0000715072-26-000072.md) | [3.8](/filings/0000715072-25-000234.md) | [3.9](/filings/0000715072-26-000072.md) | [3.9](/filings/0000715072-26-000072.md) | [3.9](/filings/0000715072-26-000072.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [79.7 d](/filings/0000715072-24-000186.md) | [100 d](/filings/0000715072-26-000017.md) | [65.1](/filings/0000715072-25-000180.md) | [(49.1) d](/filings/0000715072-25-000211.md) | [(1.7) d](/filings/0000715072-25-000234.md) | [92.1 d](/filings/0000715072-26-000017.md) | [50.1](/filings/0000715072-26-000046.md) | [(30.6) d](/filings/0000715072-26-000072.md) | [145 d](/filings/0000715072-25-000234.md) | [107 d](/filings/0000715072-26-000017.md) | [100](/filings/0000715072-26-000046.md) | [82.4 d](/filings/0000715072-26-000072.md) |
| Capital expenditure | $m | [4.0 d](/filings/0000715072-24-000186.md) | [5.2 d](/filings/0000715072-26-000017.md) | [3.3](/filings/0000715072-25-000180.md) | [3.5 d](/filings/0000715072-25-000211.md) | [3.6 d](/filings/0000715072-25-000234.md) | [3.2 d](/filings/0000715072-26-000017.md) | [4.8](/filings/0000715072-26-000046.md) | [10.2 d](/filings/0000715072-26-000072.md) | [15.3 d](/filings/0000715072-25-000234.md) | [3.4 d](/filings/0000715072-26-000017.md) | [6.3](/filings/0000715072-26-000046.md) | [6.0 d](/filings/0000715072-26-000072.md) |
| Dividends paid | $m | [12.6 d](/filings/0000715072-24-000186.md) | [12.6 d](/filings/0000715072-26-000017.md) | [12.7](/filings/0000715072-25-000180.md) | [12.6 d](/filings/0000715072-25-000211.md) | [14.2 d](/filings/0000715072-25-000234.md) | [14.2 d](/filings/0000715072-26-000017.md) | [14.3](/filings/0000715072-26-000046.md) | [21.2 d](/filings/0000715072-26-000072.md) | [21.2 d](/filings/0000715072-25-000234.md) | [22.0 d](/filings/0000715072-26-000017.md) | [21.6](/filings/0000715072-26-000046.md) | [22.2 d](/filings/0000715072-26-000072.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0000715072-26-000046.md) | [0.0 d](/filings/0000715072-26-000072.md) | not reported | not reported | [75.8](/filings/0000715072-26-000046.md) | [60.5 d](/filings/0000715072-26-000072.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [56.2](/filings/0000715072-23-000250.md) | [56.3](/filings/0000715072-24-000130.md) | [56.4](/filings/0000715072-24-000155.md) | [56.5](/filings/0000715072-24-000186.md) | [56.5](/filings/0000715072-25-000180.md) | [56.7](/filings/0000715072-25-000211.md) | [61.6](/filings/0000715072-25-000234.md) | [64.0](/filings/0000715072-26-000046.md) | [95.1](/filings/0000715072-26-000072.md) | [95.3](/filings/0000715072-25-000234.md) | [94.2](/filings/0000715072-26-000046.md) | [92.2](/filings/0000715072-26-000072.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 91,404,465 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0000715072-26-000072.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.